|
1
|
Eppert K, Wunder JS, Aneliunas V, Kandel R
and Andrulis IL: Von Willebrand factor expression in osteosarcoma
metastasis. Mod Pathol. 18:388–397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
4
|
Thompson LD: Osteosarcoma. Ear Nose Throat
J. 92(288): 290. 2013.
|
|
5
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Meng S. 16:942017.
|
|
6
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Z, Xie L, Han L, Qu X, Yang Y, Zhang
Y, He Z, Wang Y and Li J: Circular RNAs: Regulators of
cancer-related signaling pathways and potential diagnostic
biomarkers for human cancers. Theranostics. 7:3106–3117. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen L, Zhang S, Wu J, Cui J, Zhong L,
Zeng L and Ge S: circRNA_100290 plays a role in oral cancer by
functioning as a sponge of the miR-29 family. Oncogene.
36:4551–4561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding YQ and Liang L: Emerging roles of
circRNA_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016.PubMed/NCBI
|
|
10
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 12:3077–3079. 2010.
View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu J, Liao Q, He H, Zhong D and Yin K:
TWIST interacts with β-catenin signaling on osteosarcoma cell
survival against cisplatin. Mol Carcinog. 53:440–446. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He J, Xie Q, Xu H, Li J and Li Y: Circular
RNAs and cancer. Cancer Lett. 396:138–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer letters. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jin H, Jin X, Zhang H and Wang W: Circular
RNA hsa-circ-0016347 promotes proliferation, invasion and
metastasis of osteosarcoma cells. Oncotarget. 8:25571–25581.
2017.PubMed/NCBI
|
|
18
|
Li JF and Song YZ: Circular RNA GLI2
promotes osteosarcoma cell proliferation, migration, and invasion
by targeting miR-125b-5p. Tumour Biol. 39:10104283177099912017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
WITHDRAWN: Circular RNA hsa_circ_0001564
facilitates tumorigenesis of osteosarcoma via sponging miR-29c-3p.
Tumour Biol. 39:10104283177099892017.
|
|
20
|
Scholten DJ II, Timmer CM, Peacock JD,
Pelle DW, Williams BO and Steensma MR: Down regulation of Wnt
signaling mitigates hypoxia-induced chemoresistance in human
osteosarcoma cells. PLoS One. 9:e1114312014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
|
22
|
He R, Liu P, Xie X, Zhou Y, Liao Q, Xiong
W, Li X, Li G, Zeng Z and Tang H: circGFRA1 and GFRA1 act as ceRNAs
in triple negative breast cancer by regulating miR-34a. J Exp Clin
Cancer Res. 36:1452017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang W, Du WW, Li X, Yee AJ and Yang BB:
Foxo3 activity promoted by non-coding effects of circular RNA and
Foxo3 pseudogene in the inhibition of tumor growth and
angiogenesis. Oncogene. 35:3919–3931. 2016. View Article : Google Scholar : PubMed/NCBI
|
